Skip to content

Clinical trials

Autoimmune Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Country / region: Canada Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20053
20061
20071
20082
20091
20103
20112
20123
20133
20152
20161
20173
20182
20192
20203
20213
20225
20234
20246
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Recruiting11
Terminated5
Active, not recruiting4
Unknown status4
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
GlaxoSmithKline3
Human Genome Sciences Inc., a GSK Company3
Novartis Pharmaceuticals3
CRISPR Therapeutics AG2
Immunovant Sciences GmbH2
McGill University2
McGill University Health Centre/Research Institute of the McGill University Health Centre2
Pfizer2
University Health Network, Toronto2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases56
Immune System Diseases22
Lupus Erythematosus, Systemic13
Endocrine System Diseases8
Diabetes Mellitus, Type 17
Metabolic Diseases7
Multiple Sclerosis7
Arthritis, Rheumatoid6
Connective Tissue Diseases6
Diabetes Mellitus5

Trials

Showing 51 to 56 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.